Tabea Wilhelm

Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial

Georgina V. Long, Uwe Trefzer, Michael A. Davies et al. · The Lancet Oncology · 2012 · 901 citations

Medicine, Melanoma, Pathology +6

The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network

Caroline Voskens, Simone M. Goldinger, Carmen Loquai et al. · PLoS ONE · 2013 · 463 citations · Full text

Phase II Trial (BREAK-2) of the BRAF Inhibitor Dabrafenib (GSK2118436) in Patients With Metastatic Melanoma

Paolo A. Ascierto, David R. Minor, Antoni Ribas et al. · Journal of Clinical Oncology · 2013 · 422 citations

GABAB receptor antibodies in paraneoplastic cerebellar ataxia

Sven Jarius, Florian Steinmeyer, Astrid Knobel et al. · Journal of Neuroimmunology · 2013 · 73 citations

Neurological Disorder, Medicine, Neurology +4

Brain morphology alterations in the basal ganglia and the hypothalamus following prenatal exposure to antiepileptic drugs

Chrysanthy Ikonomidou, Ianina Scheer, Tabea Wilhelm et al. · European Journal of Paediatric Neurology · 2007 · 65 citations

Psychiatry, Neurophysiology, Neuroanatomy +14